AVTR official logo AVTR
AVTR 1-star rating from Upturn Advisory
Avantor Inc (AVTR) company logo

Avantor Inc (AVTR)

Avantor Inc (AVTR) 1-star rating from Upturn Advisory
$11.28
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/15/2025: AVTR (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

4 star rating from financial analysts

21 Analysts rated it

Well-followed company, solid analyst reports, reliable data for confident investing.

1 Year Target Price $13.64

1 Year Target Price $13.64

Analysts Price Target For last 52 week
$13.64 Target price
52w Low $10.62
Current$11.28
52w High $23.32

Analysis of Past Performance

Type Stock
Historic Profit -29.76%
Avg. Invested days 28
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/15/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 7.62B USD
Price to earnings Ratio -
1Y Target Price 13.64
Price to earnings Ratio -
1Y Target Price 13.64
Volume (30-day avg) 21
Beta 0.93
52 Weeks Range 10.62 - 23.32
Updated Date 12/14/2025
52 Weeks Range 10.62 - 23.32
Updated Date 12/14/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.13

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -1.25%
Operating Margin (TTM) 8.48%

Management Effectiveness

Return on Assets (TTM) 3.43%
Return on Equity (TTM) -1.48%

Valuation

Trailing PE -
Forward PE 11.71
Enterprise Value 11221871975
Price to Sales(TTM) 1.16
Enterprise Value 11221871975
Price to Sales(TTM) 1.16
Enterprise Value to Revenue 1.71
Enterprise Value to EBITDA 17.41
Shares Outstanding 681814859
Shares Floating 663712674
Shares Outstanding 681814859
Shares Floating 663712674
Percent Insiders 1.39
Percent Institutions 102.26

About Avantor Inc

Exchange NYSE
Headquaters Radnor, PA, United States
IPO Launch date 2019-05-17
President & CEO Mr. Emmanuel Ligner
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 13500
Full time employees 13500

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.